Researcher
Filip Van Hauwermeiren
- Disciplines:Palliative care and end-of-life care, Laboratory medicine, Nursing, Other basic sciences, Regenerative medicine, Other paramedical sciences, Other health sciences, Other medical and health sciences, Immunomodulation therapy, Clinical microbiology, Other translational sciences not elsewhere classified, Other clinical sciences not elsewhere classified
Affiliations
- Department of Internal medicine (Department)
Member
From1 Oct 2013 → 25 Mar 2018 - Department of Biomedical molecular biology (Department)
Member
From1 Jan 2007 → 30 Sep 2013
Projects
1 - 2 of 2
- Inhibition of TNFR1 for the treatment of TNF-mediated pathologiesFrom1 Jan 2014 → 31 Dec 2016Funding: FWO research project (including WEAVE projects)
- Inhibition of TNFR1 for the treatment of TNF mediated diseasesFrom1 Oct 2013 → 25 Mar 2018Funding: BOF - Other initiatives, FWO fellowships
Publications
21 - 30 of 30
- LPS resistance of SPRET/Ei mice is mediated by Gilz, encoded by the Tsc22d3 gene on the X chromosome(2013)
Authors: Iris Pinheiro, Lien Dejager, Sofie Vandevyver, Leen Puimège, Tina Mahieu, Filip Van Hauwermeiren, Carlo Riccardi, Marnik Vuylsteke, Claude Libert
Pages: 456 - 470 - Safe TNF-based antitumor therapy following p55TNFR reduction in intestinal epithelium(2013)
Authors: Filip Van Hauwermeiren, Marietta Armaka, Niki Karagianni, Ksanthi Kranidioti, Sonja Loges, Maarten Van Royen, Jan Staelens, Leen Puimège, Ajay Palagani, Panayiotis Victoratos, et al.
Pages: 2590 - 2603 - Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models(2012)
Authors: Linde Duprez, Sasker Grootjans, Wim Nerinckx, JB DuHadaway, Ria Roelandt, Filip Van Hauwermeiren, Claude Libert, GC Prendergast, A Degterev, J Yuan, et al.
- Matrix metalloprotease 8-dependent extracellular matrix cleavage at the blood-CSF barrier contributes to lethality during systemic inflammatory diseases(2012)
Authors: Eline Dejonckheere, Philippe Van Lint, Delphine Demeestere, Elien Van Wonterghem, Ineke Vanlaere, Leen Puimège, Filip Van Hauwermeiren, Conor Mc Guire, Cristina Campestre, Carlos López-Otin, et al.
Pages: 9805 - 9816 - Tumor necrosis factor Inhibits glucocorticoid receptor function in mice a strong signal toward lethal shock(2011)
Authors: Tom Van Bogaert, Sofie Vandevyver, Lien Dejager, Filip Van Hauwermeiren, Iris Pinheiro, David Engblom, Anna Kleyman, Guenther Schutz, Jan Tuckermann, Claude Libert
Pages: 26555 - 26567 - Treatment of TNF mediated diseases by selective inhibition of soluble TNF or TNFR1(2011)
Authors: Filip Van Hauwermeiren, Claude Libert
Pages: 311 - 319 - RIP Kinase-dependent necrosis drives lethal systemic inflammatory response syndrome(2011)
Authors: Linde Duprez, Filip Van Hauwermeiren, Benjamin Vandendriessche, Tom Vanden Berghe, Claude Libert, Peter Vandenabeele
Pages: 908 - 918 - Strategies to inhibit the toxicity of systemic TNF treatment(2011)
Authors: Filip Van Hauwermeiren, Leen Puimège, Sofie Vandevyver, Tom Van Bogaert, Ineke Vanlaere, Liesbeth Huys, Lien Dejager, Claude Libert, D Wallach, A Kovalenko, et al.
Pages: 481 - 484 - New strategies to prevent TNF-induced toxicity in TNF/IFNU+03B3-based anti-tumor models(2011)
Authors: Filip Van Hauwermeiren
- Type I interferon drives tumor necrosis factor-induced lethal shock(2009)
Authors: Liesbeth Huys, Filip Van Hauwermeiren, Lien Dejager, Eline Dejonckheere, Stefan Lienenklaus, Siegfried Weiss, Georges Leclercq, Claude Libert
Pages: 1873 - 1882